The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has warned stating a common painkiller, diclofenac, raises the risk of heart attack and stroke among patients with serious underlying heart conditions. The most common painkiller drug Diclofenac is sold under colossal trade names such as Diclomax, Defenac, Diclofex, Dyloject, Econac, Enstar, Flamrase, Flamatak, Motifene, Rheumatac, Rhumalgan, Volsaid, and Voltarol. Reviews of Diclofenac and related medicines carried out during 2005, 2006 and 2012 have confirmed that NSAIDs class are associated with a small increased risk of arterial thromboembolic events (blood clots in the arteries) especially in those patients with underlying heart or circulatory conditions.
For all NSAIDs MHRA recommends that these medicines may be used at the lowest effective dose for the shortest period of time necessary to control symptoms.
MNT, 01 Jul 2013